NPLATE romiplostim (rbe) 230 microgram powder for injection vial

Amgen Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 926a4e96d0005ebd
Product Name: NPLATE romiplostim (rbe) 230 microgram powder for injection vial
Artg Id: 283890
Artg Name: NPLATE romiplostim (rbe) 230 microgram powder for injection vial
Sponsor: Amgen Australia Pty Ltd
Company Detail Path: /organization/amgen-australia-pty-ltd
Artg Date: 2017-10-23
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Product Information: https://medical-cdn.nocode.com/drug_tga/2393e2ab04828cf2f1e4319b559ca0f4.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

926a4e96d0005ebd

Type

Standard